Partnership with Clyra Medical expands federal access to FDA 510(k)-cleared wound cleansing, irrigation, and debridement powered by Clyrasept™ Copper-Iodine.

BioLargo subsidiary Clyra enters an exclusive reseller agreement with Spartan Medical for ViaCLYR wound care solution targeting U.S. government facilities and ECAT listing amid expanding wound care demand.

Service-disabled veteran-owned company expands federal access to domestically manufactured medical supplies.

The Ortho350 is a portable, low-dose, FDA cleared 3D tomosynthesis system designed to provide advanced extremity imaging at the point of care.

In recognition of Memorial Day and in honor of the men and women who have served our country, Gel4Med, Inc. (“Gel4Med”), a leader in advanced biomaterials engineering, today reaffirmed its commitment to supporting veteran care by providing access to two novel wound care and surgical reconstruction technologies, G4Derm™ Plus Biomimetic Matrix and Suprello™ Surgical Wound Matrix, across both federal and non-federal healthcare settings.

Spartan Medical proudly supports the HHS & USDA initiatives of providing real food to help prevent chronic disease for American families.

Spartan Medical Inc. today announced the addition of Osteogene’s InRoad® Dental Synthetic Bone Graft to the Defense Logistics Agency Electronic Catalog (ECAT).

Partnership strengthens Headsafe’s U.S. commercialization with established contracting, logistics, and distribution capabilities.

Spartan Medical® and SI-BONE® announce new partnership to expand access to advanced ultra–minimally invasive treatment options for sacroiliac joint dysfunction.